JP2019517813A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019517813A5 JP2019517813A5 JP2018566226A JP2018566226A JP2019517813A5 JP 2019517813 A5 JP2019517813 A5 JP 2019517813A5 JP 2018566226 A JP2018566226 A JP 2018566226A JP 2018566226 A JP2018566226 A JP 2018566226A JP 2019517813 A5 JP2019517813 A5 JP 2019517813A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- seq
- human
- chain comprises
- item
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662351054P | 2016-06-16 | 2016-06-16 | |
| US62/351,054 | 2016-06-16 | ||
| PCT/US2017/037533 WO2017218691A1 (en) | 2016-06-16 | 2017-06-14 | Humanized and chimeric monoclonal antibodies to cd81 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019517813A JP2019517813A (ja) | 2019-06-27 |
| JP2019517813A5 true JP2019517813A5 (https=) | 2020-07-27 |
Family
ID=60664252
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018566226A Pending JP2019517813A (ja) | 2016-06-16 | 2017-06-14 | Ｃｄ８１に対するヒト化及びキメラモノクローナル抗体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10815306B2 (https=) |
| EP (1) | EP3471762A4 (https=) |
| JP (1) | JP2019517813A (https=) |
| CN (1) | CN109414492A (https=) |
| BR (1) | BR112018076247A2 (https=) |
| CA (1) | CA3027942A1 (https=) |
| MA (1) | MA45404A (https=) |
| RU (1) | RU2019100102A (https=) |
| WO (1) | WO2017218691A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12486321B2 (en) | 2020-01-21 | 2025-12-02 | Tavotek Biotechnology (Jiangsu) Co., Ltd | Agents that interfere with IL-1BETA receptor signalling |
| JP2025536268A (ja) | 2022-10-12 | 2025-11-05 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | Ｔ細胞悪性腫瘍におけるバイオマーカー及びバイオターゲットとしてのｃｄ８１ |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US6096871A (en) | 1995-04-14 | 2000-08-01 | Genentech, Inc. | Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life |
| JP4046354B2 (ja) | 1996-03-18 | 2008-02-13 | ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム | 増大した半減期を有する免疫グロブリン様ドメイン |
| WO2006037604A1 (en) * | 2004-10-01 | 2006-04-13 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Novel antibodies directed to the mammalian eag1 ion channel protein |
| EP1885396A2 (en) * | 2005-05-04 | 2008-02-13 | Quark Pharmaceuticals, Inc. | Recombinant antibodies against cd55 and cd59 and uses thereof |
| DK2439273T3 (da) * | 2005-05-09 | 2019-06-03 | Ono Pharmaceutical Co | Humane monoklonale antistoffer til programmeret død-1(pd-1) og fremgangsmåder til behandling af cancer ved anvendelse af anti-pd-1- antistoffer alene eller i kombination med andre immunterapeutika |
| EP1790664A1 (en) | 2005-11-24 | 2007-05-30 | Ganymed Pharmaceuticals AG | Monoclonal antibodies against claudin-18 for treatment of cancer |
| US7858752B2 (en) | 2006-12-05 | 2010-12-28 | Abbott Laboratories | Recombinant antibodies against hepatitis C virus and methods of obtaining and using same |
| WO2011016238A1 (en) | 2009-08-06 | 2011-02-10 | Immunas Pharma, Inc. | Antibodies that specifically bind to a beta oligomers and use thereof |
| WO2011156520A2 (en) | 2010-06-09 | 2011-12-15 | Green Pacific Biologicals, Inc. | Compositions and methods for increasing oil production and secretion |
| KR20130132904A (ko) * | 2010-12-06 | 2013-12-05 | 다이닛본 스미토모 세이야꾸 가부시끼가이샤 | 인간 모노클로날 항체 |
| US8440797B2 (en) * | 2010-12-06 | 2013-05-14 | Dainippon Sumitomo Pharma Co., Ltd. | Human monoclonal antibody |
| WO2014063368A1 (zh) * | 2012-10-26 | 2014-05-01 | 中国医学科学院基础医学研究所 | 抗人死亡受体5胞外区的人源化单克隆抗体 |
-
2017
- 2017-06-14 BR BR112018076247-4A patent/BR112018076247A2/pt not_active Application Discontinuation
- 2017-06-14 CN CN201780040994.1A patent/CN109414492A/zh active Pending
- 2017-06-14 JP JP2018566226A patent/JP2019517813A/ja active Pending
- 2017-06-14 US US16/308,113 patent/US10815306B2/en active Active
- 2017-06-14 EP EP17814033.1A patent/EP3471762A4/en not_active Withdrawn
- 2017-06-14 RU RU2019100102A patent/RU2019100102A/ru not_active Application Discontinuation
- 2017-06-14 WO PCT/US2017/037533 patent/WO2017218691A1/en not_active Ceased
- 2017-06-14 MA MA045404A patent/MA45404A/fr unknown
- 2017-06-14 CA CA3027942A patent/CA3027942A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6971153B2 (ja) | 多重特異的ｎｋエンゲイジャータンパク質 | |
| CN107532188B (zh) | Cd20结合分子及其用途 | |
| JP2025118630A (ja) | 抗ＳＩＲＰ－α抗体及びその使用方法 | |
| CN111484555B (zh) | 新型双特异性cd3/cd20多肽复合物 | |
| CA3175140A1 (en) | Novel anti-lilrb4 antibodies and derivative products | |
| AU2019200164A1 (en) | Humanized anti-CD134 (OX40) antibodies and uses thereof | |
| CN109475603A (zh) | 抗pd-l1抗体 | |
| IL268593B2 (en) | Polypeptides and antibodies having increased cdc and/or agonistic activity and their uses in medicine | |
| KR20180083944A (ko) | 항체 및 이의 사용 방법 | |
| JP2018510636A5 (https=) | ||
| JP2014519322A5 (https=) | ||
| JP2015533853A5 (https=) | ||
| WO2020227457A1 (en) | Materials and methods for modulating t cell mediated immunity | |
| KR20240067052A (ko) | 항-ccr8 항체 | |
| JP2017537082A5 (https=) | ||
| JP6548052B2 (ja) | 抗体 | |
| JP2019535306A5 (https=) | ||
| TW202016142A (zh) | 用於治療癌症之組合物及方法 | |
| AU2018241916A1 (en) | PD-L1 and TA-MUC1 antibodies | |
| JP2023518189A (ja) | デルタ鎖媒介性免疫を調節するための材料及び方法 | |
| CN113840839B (zh) | 人源化和亲和力成熟的抗ceacam1抗体 | |
| KR20230156727A (ko) | 항-vsig4 항체 또는 이의 항원 결합 단편 및 용도 | |
| JP2019517813A5 (https=) | ||
| KR20240055016A (ko) | 면역억제성 b 세포와 연관된 암을 치료하는 방법 | |
| CA3146977A1 (en) | Antibody constructs binding 4-1bb and folate receptor alpha and uses thereof |